338 related articles for article (PubMed ID: 8651045)
1. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
Geyer G; Haidinger G; Francesconi M; Langmayr N; Prager R; Schoberberger R; Toplak H; von Kalckreuth G; Kunze M
Acta Med Austriaca; 1995; 22(5):95-101; 104-9. PubMed ID: 8651045
[TBL] [Abstract][Full Text] [Related]
2. [A multicenter open study of dexfenfluramine in Italy. The efficacy and safety of using dexfenfluramine in treating patients with simple or complicated obesity. The DIMOS Group].
Enzi G
Ter Arkh; 1997; 69(5):71-5. PubMed ID: 9235665
[TBL] [Abstract][Full Text] [Related]
3. [Tolerance and acceptability of dexfenfluramine in the long-term treatment of obesity in private practice. ESIM Group].
Héraïef E
Rev Med Suisse Romande; 1997 Jan; 117(1):19-24. PubMed ID: 9082531
[TBL] [Abstract][Full Text] [Related]
4. Prolonged weight loss with dexfenfluramine treatment in obese patients.
Finer N; Craddock D; Lavielle R; Keen H
Diabete Metab; 1987; 13(6):598-602. PubMed ID: 3329122
[TBL] [Abstract][Full Text] [Related]
5. A close look at fenfluramine and dexfenfluramine.
Vivero LE; Anderson PO; Clark RF
J Emerg Med; 1998; 16(2):197-205. PubMed ID: 9543401
[TBL] [Abstract][Full Text] [Related]
6. Somatometric and hormonal effects of dexfenfluramine.
Sonka J; Marek J; Svacina S; Sucharda P; Stĕpán J
Sb Lek; 1995; 96(4):299-301. PubMed ID: 8711372
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of dexfenfluramine in a weight loss program for obese infertile women.
Galletly C; Clark A; Tomlinson L
Int J Eat Disord; 1996 Mar; 19(2):209-12. PubMed ID: 8932560
[TBL] [Abstract][Full Text] [Related]
8. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
Sabuncu T; Ucar E; Birden F; Yasar O
Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102
[TBL] [Abstract][Full Text] [Related]
9. Possible thermogenesis with dexfenfluramine.
Roongpisuthipong C; Panpakdee O; Boontawee A; Kulapongse S; Tanphaichitr V
J Med Assoc Thai; 1999 Feb; 82(2):150-9. PubMed ID: 10087722
[TBL] [Abstract][Full Text] [Related]
10. The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks.
Drent ML; Zelissen PM; Koppeschaar HP; Nieuwenhuyzen Kruseman AC; Lutterman JA; van der Veen EA
Int J Obes Relat Metab Disord; 1995 May; 19(5):299-304. PubMed ID: 7647820
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of dexfenfluramine treatment in obese adolescents].
Małecka-Tendera E; Koehler B; Muchacka M; Wazowski R; Trzciakowska A
Pediatr Pol; 1996 May; 71(5):431-6. PubMed ID: 8710426
[TBL] [Abstract][Full Text] [Related]
12. The effects of dexfenfluramine on weight loss and cardiovascular risk factors in female patients with upper and lower body obesity.
Ditschuneit HH; Flechtner-Mors M; Adler G
J Cardiovasc Risk; 1996 Aug; 3(4):397-403. PubMed ID: 8946272
[TBL] [Abstract][Full Text] [Related]
13. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
Mathus-Vliegen EM;
Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
[TBL] [Abstract][Full Text] [Related]
14. [Sustained weight reduction after cessation of obesity treatment with Sibutramine].
Wirth A
Dtsch Med Wochenschr; 2004 Apr; 129(18):1002-5. PubMed ID: 15131746
[TBL] [Abstract][Full Text] [Related]
15. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
O'Connor HT; Richman RM; Steinbeck KS; Caterson ID
Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
[TBL] [Abstract][Full Text] [Related]
16. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
Hainer V; Kunesova M; Bellisle F; Hill M; Braunerova R; Wagenknecht M
Int J Obes (Lond); 2005 Feb; 29(2):208-16. PubMed ID: 15583700
[TBL] [Abstract][Full Text] [Related]
17. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
Early JL; Apovian CM; Aronne LJ; Fernstrom MH; Frank A; Greenway FL; Heber D; Kushner RF; Cwik KM; Walch JK; Hewkin AC; Blakesley V
Obesity (Silver Spring); 2007 Jun; 15(6):1464-72. PubMed ID: 17557984
[TBL] [Abstract][Full Text] [Related]
18. [Different therapies in the treatment of obesity in hypertensive patients].
Monego ET; Peixoto Mdo R; Jardim PC; Sousa AL; Braga VL; Moura MF
Arq Bras Cardiol; 1996 Jun; 66(6):343-7. PubMed ID: 9035450
[TBL] [Abstract][Full Text] [Related]
19. [Drug therapy of obesity--results of treatment with dexfenfluramine].
Ivković-Lazar T; Stokić E; Lepsanović L
Med Pregl; 1990; 43(5-6):232-5. PubMed ID: 2287309
[TBL] [Abstract][Full Text] [Related]
20. Prolonged use of a very low calorie diet (Cambridge diet) in massively obese patients attending an obesity clinic: safety, efficacy and additional benefit from dexfenfluramine.
Finer N; Finer S; Naoumova RP
Int J Obes; 1989; 13 Suppl 2():91-3. PubMed ID: 2613434
[No Abstract] [Full Text] [Related]
[Next] [New Search]
